Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice.
Roberts
N A
NA
Roche Discovery, Welwyn Garden City, Hertfordshire, UK.
Craig
J C
JC
Sheldon
J
J
D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D006678:HIV / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009154:Mutation; D019258:Saquinavir / Q000494:pharmacology* / Q000627:therapeutic use; D014779:Virus Replication
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019258:Saquinavir